Press ReleaseAIMHI_wpuser2024-08-29T11:16:30+00:00

Press Release

Press Release

Congratulations to our Top Two Finalists and the People’s Choice Award Winner!

AIMHI_wpuser2025-02-21T16:00:09+00:00September 29, 2020|Press Release|

Support Women Scientist-Entrepreneurs in Celebration of the Women’s Equality Day

AIMHI_wpuser2025-02-21T16:00:09+00:00August 25, 2020|Press Release|

AIM-HI Portfolio Company Profile: Rasio Therapeutics

AIMHI_wpuser2025-02-21T16:00:09+00:00August 10, 2020|Press Release|

AIM-HI Announces Semi-Finalists in Women’s Venture Competition, Finalists Announced Sept. 24

AIMHI_wpuser2025-02-21T16:00:09+00:00August 7, 2020|Press Release|

AIM-HI Portfolio Company Profile: Tvardi Therapeutics

AIMHI_wpuser2025-02-21T16:00:09+00:00July 29, 2020|Press Release|

Tvardi’s TTI-101 Receives $5 Million in Funding to Support Clinical Trials and Translational Research

AIMHI_wpuser2025-02-21T16:00:10+00:00July 24, 2020|Press Release|

Previous 8910 Next

AIMhi

AIM-HI Accelerator Fund is a 501(c)(3) tax-exempt nonprofit organization.

Tax ID #: 82-4322538

Address:

5515 Security Lane, Suite 1105
Rockville, MD 20852

Email:

info@aim-hiaccelerator.org

Phone:

1-800-321-CURE (2873)

what we do

Copyright © AIM-HI 2025 All Rights Reserved

AIMhi

AIM-HI Accelerator Fund is a 501(c)(3) tax-exempt nonprofit organization.

Tax ID #: 82-4322538

Copyright © AIM-HI 2025 All Rights Reserved